Status:

UNKNOWN

Efficacy of Natural Seawater Based Throat Spray in Acute Sore Throat Relief

Lead Sponsor:

Laboratoire de la Mer

Conditions:

Sore Throat

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Prospective, randomized, double-blind, placebo-controlled, multicentre clinical trial to assess the efficacy and tolerability of natural seawater based throat spray among adult patients with acute sor...

Eligibility Criteria

Inclusion

  • 1\. Adults (male or female) aged ≥ 18 years old.
  • 2\. Patients with complaint of sore throat ≤ 72h.
  • 3\. Sore throat exclusively due to upper respiratory tract infection (tonsillitis, pharyngitis, rhinopharyngitis).
  • 4\. Clinical confirmation by the physician for the presence of typical signs (spontaneous pain, local inflammation) of acute pharyngitis or tonsillitis.
  • 5\. Pain intensity scored by patient on the 5-point descriptive pain intensity scale as slight, mild or moderate.
  • 6\. Willingness to provide written informed consent prior to perform of any study related procedure.
  • 7\. Subjects agreeing to follow the study requirements during the whole study period (including forbidden medication and food supplements).
  • 8\. Subjects agreeing not to modify their lifestyle habits during the whole study period (diet, physical activity).
  • 9\. Subject affiliated to social security.
  • 10\. Subject able to understand verbal and written local language and in capacity to fill-in patient diary by himself/herself.

Exclusion

  • 1\. Previous history of allergy or known intolerance to one of the following formulation ingredients: seawater, vegetable glycerin, mint, lemon, acacia honey, propolis, essential oils.
  • 2\. Active Smokers.
  • 3\. Fever \> 38°C at randomization.
  • 4\. Past or current throat phlegmon.
  • 5\. Past or current seasonal allergy.
  • 6\. Past or current asthma.
  • 7\. Past or current chronic rhinosinusitis.
  • 8\. Past or current chronic obstructive pulmonary disease (COPD).
  • 9\. Past or current ENT (Ear, Nose and Throat) cancer.
  • 10\. Acute rhinosinusitis.
  • 11\. Controlled or uncontrolled diabetes.
  • 12\. Gastroesophageal reflux disease (GERD).
  • 13\. Known immunodeficiency.
  • 14\. Any painful condition that may distract attention from sore throat pain (ex: mouth ulcers etc.) or that requires analgesic usage.
  • 15\. Any disease that may interfere with the study aim from investigator's opinion.
  • 16\. Evidence of mouth breathing or severe coughing.
  • 17\. Patient with severe pain intensity on 5-point descriptive pain intensity scale.
  • 18\. Subjects taking:
  • chronic treatment for throat or other ENT pathology,
  • current antibiotherapy or stopped less than 2 weeks before inclusion,
  • chronic treatment (\>3 months) with local or systemic corticotherapy, or immunotherapy,
  • local or systemic antihistaminic.
  • 19\. Subjects refusing to stop at entry into the study:
  • throat spray, lozenge, pastille,
  • local throat or systemic analgesic,
  • medicated confectionary,
  • nasal wash and spray,
  • nasal corticosteroid or antihistaminic nasal spray,
  • medication to gargle,
  • honey, propolis, or any sore throat home remedies.
  • 20\. Known liver disease or hypersensitivity to paracetamol.
  • 21\. Pregnant, breastfeeding or seeking pregnancy women.
  • 22\. Positive result from rapid strep throat test.
  • 23\. Subjects already included once in this study.
  • 24\. Subjects participating in another clinical trial or in the exclusion period to another study.
  • 25\. Subjects having a member of his/her home who is currently participating to this study.

Key Trial Info

Start Date :

November 6 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 30 2018

Estimated Enrollment :

360 Patients enrolled

Trial Details

Trial ID

NCT03369132

Start Date

November 6 2017

End Date

September 30 2018

Last Update

December 22 2017

Active Locations (16)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (16 locations)

1

MUDr. Lenka Dybova

Brno, Czechia, 602 00

2

MUDr. Libor Hemzsky

Choltice, Czechia, 533 61

3

NEFROMED s.r.o.

Dejvice, Czechia, 160 00

4

MEDIGATE care s.r.o

Hradec Králové, Czechia, 500 09